This inventor holds 2 USPTO granted patents. Top assignee: Cornell University. Active years: 1999-2000.
Company Filing History:
Years Active: 1999-2000
Title: Leandros Arvanitakis: Innovator in G Protein Coupled Receptor Research
Introduction
Leandros Arvanitakis is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biomedical research, particularly in the study of G protein coupled receptors. With a total of 2 patents, his work has implications for understanding and treating various diseases.
Latest Patents
Arvanitakis's latest patents include innovative methods for identifying negative antagonists for G protein coupled receptors. One patent focuses on a constitutively active G protein coupled receptor of human herpesvirus 8. This invention outlines a method for identifying negative antagonists by co-expressing a receptor and a reporter protein in a host cell. The effectiveness of test substances as negative antagonists can be determined through the activity of the reporter protein. Additionally, he has developed a method to prevent tumor formation or cell proliferation caused by these receptors.
Another significant patent involves the creation of cell lines comprising Kaposi's sarcoma-associated herpesvirus (KSHV). This invention provides two cell lines, designated BC-2 and BC-3, which can be used to propagate KSHV. The BC-3 cell line is particularly noteworthy as it allows for propagation in the absence of Epstein-Barr virus, offering new avenues for research in virology.
Career Highlights
Leandros Arvanitakis is affiliated with Cornell University, where he conducts his research. His work has garnered attention in the scientific community, contributing to advancements in understanding viral mechanisms and potential therapeutic approaches.
Collaborations
Arvanitakis has collaborated with esteemed colleagues such as Ethel Cesarman and Marvin C Gershengorn. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
Leandros Arvanitakis stands out as an influential inventor in the realm of biomedical research, with a focus on G protein coupled receptors and viral studies. His patents reflect a commitment to advancing scientific knowledge and developing potential therapeutic strategies.